OSCEs in Obstetrics and Maternal-Fetal Medicine

Amira El-Messidi graduated with an MDCM degree from McGill University in 2002. After completion of her residency and fellowship at the University of Ottawa, she joined McGill as a staff in 2009 and is currently an Associate Professor at McGill's Department of Obstetrics & Gynecology and Consultant of Maternal-Fetal Medicine. Her career contributions to excellence in postgraduate education have attracted honours including 10 departmental awards to date, a scholarship to McGill's 'Teachers' Scholars Program for Educators in Health Science', the Faculty of Medicine's Maude-Abbott Prize, the Carl Nimrod Educator Award for Excellence in Education, the National Faculty Award from the American College of Obstetricians & Gynaecologists' Council on Resident Education, and the Excellence in Teaching Award from the Association of Professors of Gynecology and Obstetrics. She served as examiner for the Medical Council of Canada and Royal College of Physicians & Surgeons of Canada for both Obstetrics & Gynaecology and Maternal-Fetal Medicine. She was also Associate Editor for the Journal of Obstetrics and Gynaecology Canada. Her main research interests are in hypertensive syndromes and diabetes in pregnancy. She has numerous publications in peer-reviewed journals. Alan D. Cameron was a Consultant Obstetrician in Glasgow for 28 years. He undertook his subspeciality training in Maternal Fetal Medicine in the University of Calgary, Alberta, Canada. He was rewarded with an Honorary Professorship from the University of Glasgow in 2007. His main research interests are in prenatal diagnosis and fetal therapy. He has published over 100 articles on peer reviewed journals and 13 chapters in textbooks. He was the main author for 'Fetal Medicine for the MRCOG and beyond' originally published in 2003 with a second edition in 2011. He was President of the British Maternal and Fetal Medicine Society from 2005–08. From 2013–16 he was Vice President for Clinical Quality at the RCOG. In 2019 he was appointed as the national clinical lead for obstetrics to the Maternity and Children Quality Improvement Collaborative (MCQIC). In 2020 Alan was the local president of the International Society of Ultrasound in Obstetrics and Gynaecology (ISUOG) virtual congress and scientific chair for the EBCOG Hybrid congress in 2021. Alan has been a speciality maternity advisor to Healthcare Safety Investigation Branch since 2019 and was appointed as clinical advisor to HSIB in 2020.

Section I. Obstetric aspects of antenatal care: foreword; 1. Routine prenatal care and immunizations; 2. Advanced maternal age; 3. Teenage pregnancy; 4. Hyperemesis gravidarum; 5. Prenatal genetic screening; 6. Obesity in pregnancy; 7. Preterm labor; 8. Incompetent cervix; 9. Fetal growth restriction; 10. Alloimmunization; 11. Multiple gestation: dichorionic pregnancy; 12. Multiple gestation: monochorionic pregnancy; 13. Prenatal care of fetal congenital anomalies; 14. Intrauterine fetal death; Section II. Labor & Delivery: 15. Labor at term; 16. Post-term pregnancy and induction of labor; 17. Counselling: cesarean section on-demand; 18. Trial of labor after cesarean section; 19. Shoulder dystocia; 20. Fetal malpresentation and breech delivery; 21. Amniotic fluid embolism and disseminated intravascular coagulation; 22. Postpartum hemorrhage; Section III. Placental complications: 23. Placenta-accreta spectrum; Section IV. Neurological disorders in pregnancy: 24. Epilepsy in pregnancy; 25. Stroke with pregnancy; 26. Multiple sclerosis in pregnancy; 27. Myasthenia gravis in pregnancy; 28. Pregnancy with spinal cord injury; Section V. Psychiatric disorders in pregnancy: 29. Mood disorders in pregnancy and postpartum depression; 30. Schizophrenia in pregnancy; Section VI. Cardiopulmonary conditions in pregnancy: 31. Valvular heart disease in pregnancy; 32. Ischemic heart disease in pregnancy; 33. Pulmonary hypertension in pregnancy; 34. Peripartum cardiomyopathy; 35. Asthma in pregnancy; 36. Tuberculosis in pregnancy; 37. Cystic fibrosis in pregnancy; 38. Chronic hypertension and preeclampsia/HELLP complications of pregnancy; Section VII. Hepato-renal and gastrointestinal conditions in pregnancy: 39. Urosepsis in pregnancy; 40. Intrahepatic cholestasis of pregnancy; 41. Acute fatty liver of pregnancy; 42. Crohn's disease in pregnancy; 43. Ulcerative colitis in pregnancy; 44. Biliary diseases in pregnancy; 45. Pregnancy after liver transplantation; 46. Pregnancy after renal transplantation; 47. Chronic renal disease in pregnancy; 48. Dialysis in pregnancy; Section VIII. Connective tissue disorders in pregnancy: 49. Systemic lupus erythematosus and antiphospholipid antibody syndrome; 50. Marfan's syndrome; Section IX. Hematologic conditions in pregnancy: 51. Sickle-cell anemia in pregnancy; 52. Inherited thrombophilia and venous thromboembolism in pregnancy; 53. Thrombotic thrombocytopenic purpura in pregnancy; 54. Thrombocytopenia in pregnancy; Section X. Endocrine disorders in pregnancy: 55. Thyroid disease in pregnancy; 56. Gestational diabetes; 57. Pre-gestational Type I diabetes mellitus; 58. Pre-gestational Type II diabetes mellitus; Section XI. Infectious conditions in pregnancy: 59. Cytomegalovirus infection in pregnancy; 60. Hepatitis B and C in pregnancy; 61. Herpes simplex virus infection in pregnancy; 62. HIV in pregnancy; 63. Parvovirus B19 infection in pregnancy; 64. Rubella in pregnancy; 65. Syphilis in pregnancy; 66. Toxoplasmosis in pregnancy; 67. Varicella in pregnancy; 68. Zika virus infection in pregnancy; 69. SARS-CoV-2 infection in pregnancy; Section XII: Malignant conditions in pregnancy: 70. Breast cancer in pregnancy; 71. Cervical cancer in pregnancy; 72. Adnexal mass in pregnancy; 73. Lymphoid cell cancers in pregnancy; Section XIII: Miscellaneous conditions: 74. Trauma in pregnancy; 75. Alcohol and street drug use in pregnancy; 76. Opioid dependency in pregnancy; 77. Acute abdominal pain in pregnancy.